Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Mediterr J Rheumatol 2023;34(4):479-85
Effect of Hypertension on Bone Mineral Density of Patients with Rheumatoid Arthritis
Authors Information

1Omkar Rheumatology Clinic, Gaikwad Mala, Nashik, India

2Hirabai Cowasji Jehangir, Medical Research Institute, Jehangir Hospital, Pune, India

PP Jadhav, VG Patwardhan

References
  1. Ruaro B, Lems W, Pino J Del, González-Álvaro I, Castañeda S, Llorente I, et al. Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons. Front Med 2020;7:601618. https://doi.org/10.3389/fmed.2020.601618.
  2. Pouresmaeili F, Kamali Dehghan B, Kamarehei M, Yong Meng G. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag 2018;Volume 14:2029-49. https://doi.org/10.2147/TCRM.S138000.
  3. Cooper C, Coupland C MM. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54:49-52. https://doi.org/10.1136/ard.54.1.49.
  4. Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R. Threefold increased risk of hip fractures with rheumatoid arthritis in central Finland. Ann Rheum Dis 2001;60:521-2. https://doi.org/10.1136/ard.60.5.521.
  5. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAXTM and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008;19:385-97. https://doi.org/10.1007/s00198-007-0543-5.
  6. Cappuccio FP, Meilahn E, Zmuda JM, Cauley JA. High blood pressure and bone-mineral loss in elderly white women: a prospective study. Lancet 1999;354:971-5. https://doi.org/10.1016/S0140-6736(99)01437-3.
  7. Yang, Wu. Osteoporosis and Osteoporotic Fracture: Contribution of Hypertension and Anti-hypertension Medications. Austin J Clin Med 2014;11. Yang,:1009.
  8. Javed F, Khan SA, Ayers EW, Aziz EF, Akram MS, Nadkarni GN, et al. Association of hypertension and bone mineral density in an elderly African American female population. J Natl Med Assoc 2012;104:172-8. https://doi.org/10.1016/S0027-9684(15)30140-1.
  9. Zhang M, Yagang L, Ying L, Xuena P, Binbin L, Zhong G  et al. Study on the influencing factors for bone mineral density among 24831 people in Changchun. Chinese J Osteoporos 2012;2:125-7.
  10. Yang TT, Xiao-Hong LV RF. Intervention study and influential factors of elder osteoporotic fracture. Mod Prev Med 2012;39:
  11. Li C, Zeng Y, Tao L, Liu S, Ni Z, Huang Q, et al. Meta-analysis of hypertension and osteoporotic fracture risk in women and men. Osteoporos Int 2017;28:2309-18. https://doi.org/10.1007/S00198-017-4050-Z/FIGURES/5.
  12. Jadhav P, Patwardhan V. Effect of type 2 diabetes mellitus on bone mineral density in patients with rheumatoid arthritis. Indian J Rheumatol 2021;16:276. https://doi.org/10.4103/INJR.INJR_293_20.
  13. Kadam NS, Chiplonkar SA KA, VV. K. Prevalence of osteoporosis in apparently healthy adults above 40 years of age in Pune City, India. Indian J Endocr Metab 2018;22:67-73.
  14. C Libanati CJFL, J Malouf‐Sierra JR. Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment. JBMR 2019;34:1033-40.
  15. Cummings SR, Martin JS, Mcclung MR, Siris ES, Eastell R, Reid IR, et al. Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis 2009. https://doi.org/10.1056/NEJMoa0809493.
  16. Peng J, Gong Y, Zhang Y, Xiao Z, Zeng Q, Chen S. Bone mineral density in patients with rheumatoid arthritis and 4-year follow-up results. J Clin Rheumatol 2016;22:71-4. https://doi.org/10.1097/RHU.0000000000000359.
  17. Lodder MC, De Jong Z, Kostense PJ, Molenaar ETH, Staal K, Voskuyl AE, et al. Bone mineral density in patients with rheumatoid arthritis: Relation between disease severity and low bone mineral density. Ann Rheum Dis 2004;63:1576-80. https://doi.org/10.1136/ard.2003.016253.
  18. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension n.d. https://doi.org/10.1038/s41581-019-0244-2.
  19. Hanley DA, Brown JP, Tenenhouse A, Olszynski WP, Ioannidis G, Berger C, et al.Associations Among Disease Conditions, Bone Mineral Density, and Prevalent Vertebral Deformities in Men and Women 50 Years of Age and Older: Cross-Sectional Results From the Canadian Multicentre Osteoporosis Study*. 2003.
  20. Hijazi N, Alourfi Z. Association between Hypertension, Antihypertensive Drugs, and Osteoporosis in Postmenopausal Syrian Women: A Cross-Sectional Study. Adv Med 2020;2020:1-6. https://doi.org/10.1155/2020/7014212.
  21. Yang S, Nguyen ND, Center JR, Eisman JA, Nguyen T V. Association between hypertension and fragility fracture: a longitudinal study. Osteoporos Int 2014;25:97-103. https://doi.org/10.1007/s00198-013-2457-8.
  22. Yazici S, Yazici M, Korkmaz U, Erkan ME, Erdem Baki A, Erden I, et al. Relationship between blood pressure levels and bone mineral density in postmenopausal Turkish women 2011. Arch Med Sci 2011 Apr;7(2):264-70. https://doi.org/10.5114/aoms.2011.22077.
  23. Ye Z, Lu H, Liu P. Association between essential hypertension and bone mineral density: a systematic review and meta-analysis. vol. 8. 2017.
  24. Salamat MR, Salamat AH, Abedi I, Janghorbani M. Clinical Study Relationship between Weight, Body Mass Index, and Bone Mineral Density in Men Referred for Dual-Energy X-Ray Absorptiometry Scan in Isfahan, Iran. J Osteoporos 2013;2013:. https://doi.org/10.1155/2013/205963.
  25. Hoxha R, Islami H, Qorraj-Bytyqi H, Thaçi S, Bahtiri E. Relationship of Weight and Body Mass Index with Bone Mineral Density in Adult Men from Kosovo. Mater Sociomed 2014. https://doi.org/10.5455/msm.2014.26.306-308.
  26. Akagi T, Mukai T, Mito T, Kawahara K, Tsuji S, Fujita S, et al. Effect of Angiotensin II on Bone Erosion and Systemic Bone Loss in Mice with Tumor Necrosis Factor-Mediated Arthritis. Int J Mol Sci 2020;21:1-19. https://doi.org/10.3390/IJMS21114145.
  27. Zhao J, Yang H, Chen B, Zhang R. The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases. Int Immunopharmacol 2019;72:258-63. https://doi.org/10.1016/J.INTIMP.2019.04.023.
  28. Kwok T, Leung J, Zhang YF, Ensrud KE, Barrett-Connor E, Leung PC. Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men? 2011. https://doi.org/10.1007/s00198-011-1831-7.
  29. Zhang YF, Qin L, Leung PC, Kwok TCY. The effect of angiotensin-converting enzyme inhibitor use on bone loss in elderly Chinese. J Bone Miner Metab 2012;30:666-73. https://doi.org/10.1007/S00774-012-0363-3.
  30. Masunari N, Fujiwara S, Nakata Y, Furukawa K, Kasagi F. Effect of angiotensin converting enzyme inhibitor and benzodiazepine intake on bone loss in older Japanese. Hiroshima J Med Sci 2008;57:17-25.
  31. Carbone LD, Vasan S, Prentice RL, Harshfield G, Haring B, Cauley JA, et al. The renin-angiotensin aldosterone system and osteoporosis: findings from the Women’s Health Initiative. Osteoporos Int 2019 3010 2019;30:2039-56. https://doi.org/10.1007/S00198-019-05041-3.
  32. Kwok T, Ohlsson C, Vandenput L, Tang N, Zhang YF, Tomlinson B, et al. ACE inhibitor use was associated with lower serum dehydroepiandrosterone concentrations in older men. Clin Chim Acta 2010;411:1122-5. https://doi.org/10.1016/J.CCA.2010.04.011.
  33. Kirby DJ, Buchalter DB, Anil U, Leucht P. DHEA in bone: the role in osteoporosis and fracture healing. Arch Osteoporos 2020;15:84. https://doi.org/10.1007/s11657-020-00755-y.
  34. Moreira FRC, de Oliveira TA, Ramos NE, Abreu MAD, Simões e Silva AC. The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis. Mol Biol Rep 2021;48:6619-29. https://doi.org/10.1007/s11033-021-06672-8.
  35. Peter Vestergaard LR& LM. Hypertension Is a Risk Factor for Fractures. Calcif Tissue Int 2009;84:103-11.
  36. U. Sennerby, B. Farahmand, A. Ahlbom SL& KM. Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int 2007;18:1355-62.
  37. Ho-Pham LT, Chau PMN, Do AT, Nguyen HC, Nguyen T V. Type 2 diabetes is associated with higher trabecular bone density but lower cortical bone density: the Vietnam Osteoporosis Study. Osteoporos Int 2018;29:2059-67. https://doi.org/10.1007/s00198-018-4579-5.
  38. Melton LJ, Riggs BL, Leibson CL, Achenbach SJ, Camp JJ, Bouxsein ML, et al. A bone structural basis for fracture risk in diabetes. J Clin Endocrinol Metab 2008;93:4804-9. https://doi.org/10.1210/jc.2008-0639.